This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastroesophageal reflux disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the stomach and the esophagus. GERD occurs when the LES relaxes too often or for too long, allowing stomach contents to flow back, or reflux, into the esophagus. This acid reflux can irritate the lining of the esophagus, causing a burning sensation known as heartburn. Common symptoms of GERD include heartburn, regurgitation, chest pain, difficulty swallowing, and a sour taste in the mouth. GERD can also cause other complications such as esophagitis, Barrett’s esophagus, and an increased risk of esophageal cancer. Risk factors for GERD include obesity, smoking, pregnancy, certain medications, and a hiatal hernia. Treatment of GERD may include lifestyle changes, medications, or surgery. Lifestyle changes such as avoiding certain foods and drinks, eating smaller meals, and not eating close to bedtime can help reduce symptoms. Medications such as antacids, H2 blockers, and proton pump inhibitors can also provide relief. In some cases, surgery may be necessary if medications and lifestyle changes do not provide adequate relief. GERD is a serious condition that can cause long-term complications if left untreated. It is important to talk to your doctor if you are experiencing symptoms of GERD to determine the best course of treatment.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States